Monday - Friday - 8:00 - 16:30   |   Weekends - Closed

Aurum Governance

The Aurum Institute is governed by a Board of Directors, supported by governance committees and led by a Group Management Executive consisting of a Group Chief Executive Officer (CEO) supported by a Technical Expert Group; a Group Chief Operations Officer (COO) and a Group Chief Financial Officer (CFO).

Prof Bernard Fourie

  • Title: Professor at Dept Medical Microbiology
  • Qualifications: MSc, PhD
  • Location: University of Pretoria

Bernard Fourie is an Extraordinary Professor and member of the research staff in the Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, South Africa. He is also associated as a Principal Investigator with the MRC Collaborating Centre for Tuberculosis Biomarker-Targeted Intervention.

Formerly, Bernard served as the Director of the National TB Research Programme of the MRC. His experience is in drug and vaccine development for TB, and in the refinement of molecular diagnostics procedures for drug resistant tuberculosis.

He has also been instrumental in the formulation and development of fixed-dose combinations of anti-tuberculosis agents and in setting up performance criteria for these. Bernard Fourie has contributed to establishing the capacity for Phase II early bactericidal activity studies in South Africa, and have been involved in clinical evaluation of several existing and new drugs against TB.
Recently, he made relevant contributions to the field of pulmonary delivery of vaccines and drugs. Current research contributions are mainly in rapid molecular diagnostics for TB, and in developing inhaled clofazimine as a new dosage form for application in drug resistant tuberculosis.

He acts as international consultant on interventions for TB and HIV for the World Health Organization, UNITAID, the United Nations Industrial Development Organization and the German Technical Cooperation (GIZ).